Nitrocellulose-Coated Film Substrates:
Ajikumar PK, Ng JK, Tang YC, Lee JY, Stephanopoulos G, Too H-P. 2006. Design, fabrication and functional analysis of a new protein array based on ssDNA-based assembly. MEBCS.
Alterovitz G, Liu J, Chow J, Ramoni MF. 2006. Automation, parallelism, and robotics for proteomics. Proteomics.
Angenendt P, GlÖkler J, Sobek J, Lehrach H, Cahill DJ. 2003. Next generation of protein microarray support materials: Evaluation for protein and antibody microarray applications. Journal of Chromatography A. 1009: 97-104.
Arnaud M-C, Gazarian T, Rodriguez YP, Gazarian K, Sakanyan V. 2004. Array assessment of phage-displayed peptide mimics of Human Immunodeficiency Virus type 1 gp41immunodominant epitope: Binding to antibodies of infected individuals. Proteomics. 4: 1959-64.
Averbeck M, Beilharz S, Bauer M, Gebhardt C, Hartmann A, Hochleitner K, Kauer F, Voith U, Simon JC, Termeer C. 2006. In situ profiling and quantification of cytokines released during UVB-induced inflammation by combining dermal microdialysis and protein microarrays. Exp. Dermatol. 15: 447-54.
Aziz SA, Davies M, Pick E, Zito C, Jilaveanu L, Camp RL, Rimm DL, Kluger Y, Kluger HM. 2009. Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma. Clinical Cancer Research. 15(9): 3029-36.
Balboni I, Chan SM, Tenenbaum JD, Butte AJ, Utz PJ. 2006. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 24: 391-418.
Barres BA, Koroshetz WJ, Chun LLY, Corey DP. 1990. Ion Channel Expression by White Matter Glia: The Type-1 Astrocyte. Neuron. 5: 527-44.
Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nährig J, Becker I, Höfler H. 2007. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 211(3): 370-8.
Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RL. 2001. Immunophenotyping of Leukemias Using a Cluster of Differentiation Antibody Microarray. Cancer Research. 61: 4483–9.
Belov L, Huang P, Barber N, Mulligan SP, Christopherson RL. 2003. Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics. 3: 2147-54.
Belov L, Huang P, Chrisp JS, Mulligan SP, Christopherson RI. 2005. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. J Immunological Methods 305: 10-19.
Bouwman K, Qiu J, Zhou H, Schotanus M, Mangold LA, Vogt R, Erlandson E, Trenkle J, Partin AW, Misek D, Omenn GS, Haab BB, Hanash S. 2003. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.
Braun F, Marhuenda FB, Morin A, Guevel L, Fleury F, Takahashi M, Sakanyan V. 2006. Similarity and divergence between the RNA polymerase a subunits from thermophilic Thermotoga maritima and mesophilic Escherichia coli bacteria. Gene 380: 120-6.
Braunschweig T, Kaserer K, Chung J-Y, Bilke S, Krizman D, Knezevic V, Hewitt SM. 2007. Proteomic expression profiling of thyroid neoplasms. Proteomics Clin. 1: 264-71.
Cahill DJ. 2001. Protein and antibody arrays and their medical applications. Journal of Immunological Methods. 250: 81-91.
Calvert VS, Tang Y, Boveia V, Wulfkuhle J, Schutz-Geschwender A, Olive DM, Liotta LA, Petricoin EF. 2004. Development of Multiplexed Protein Profiling and Detection Using Near Infrared Detection of Reverse-Phase Protein Microarrays. Proteomics. 1: 81-9.
Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Liotta LA, Petricoin EF, Younossi ZM. 2007. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology. 46(1): 166-72.
Carbone R, De Marni M, Zanardi A, Vinati S, Barborini E, Fornasari L, Milani P. 2009. Characterization of cluster-assembled nanostructured titanium oxide coatings as substrates for protein arrays. Analytical Biochemistry. 394(1): 7-12.
Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES. 2008. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood. 112(9): 3818-26.
Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. 2004. Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 10(12) 1390-6.
Chang Y-J, Hu C-Y, Yin L-T, Chang C-H, Su H-J. 2008. Dividable membrane with multi-reaction wells for microarray biochips. Journal of Bioscience and Bioengineering. 106(1): 59-64.
Charboneau L, Scott H, Chen T, Winters M, Petricoin EF, Liotta LA, Paweletz CP. 2002. Utility of reverse phase protein arrays: Applications to signalling pathways and human body arrays. Briefings in functional Genomics and Proteomics. 1(3): 305-15.
Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. 2006. Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays. Cancer Research. 66: 1181-90.
Chatterjee M, Ionan A, Draghici S, Tainsky MA. 2006. Epitomics: global profiling of immune response to disease using protein microarrays. OMICS. 10(4): 499-506.
Cho WCS. 2007. Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer. 6(25).
Christopherson RI, Stoner K, Barber N, Belov L, Woolfson A, Scott M, Bendall L, Mulligan SP. 2006. Classification of AML using a monoclonal antibody microarray. Methods Mol. Med. 125: 241-51.
Cinier M, Petit M, Williams MN, Fabre RM, Pecorari F, Talham DR, Bujoli B, Tellier C. 2009. Bisphosphonate Adaptors for Specific Protein Binding on Zirconium Phosphonate-based Microarrays. Bioconjugate Chem. 20(12): 2270-7.
Colombo JA, Napp MI, Yáñez A, Reisin H. 2001. Tissue printing of astroglial interlaminar processes from human and non-human primate cerebral cortex. Brain Research Bulletin. 55(4): 561-5.
Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, Romero KM, Nguyen TT, Kalantari-Dehaghi M, Crotty S, Baldi P, Villarreal LP, Felgner PL. 2005a. Profiling the humoral response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery. PNAS. 102(3): 547-52.
Davies DH, McCausland MM, Valdez C, Huynh D, Hernandez JE, Mu Y, Hirst S, Villarreal L, Felgner PL, Crotty S. 2005b. Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice. Journal of Virology. 79(18): 11724-33.
Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, Mu Y, Pablo J, Unal B, Nakajima-Sasaki R, Liang X, Crotty S, Karem KL, Damon IK, Ahmed R, Villarreal L, Felgner P. 2007. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics. 7: 1678-86.
Davuluri G, Espina V, Petricoin EF, Ross M, Deng J, Liotta LA, Glaser BM. 2009. Activated VEGF receptor shed into the vitreous in eyes with wet AMD. Archives of Ophthalmology. 127(5): 613-21.
Dinca V, Catherine J, Mourka A, Georgiou S, Farsari M, Fotakis C. 2009. 2D and 3D biotin patterning by ultrafast lasers. International ournal of Nanotechnology. 6(1-2): 88-98.
Dinca V, Farsari M, Kafetzopoulos D, Popescu A, Dinescu M, Fotakis C. 2008. Patterning parameters for biomolecules microarrays constructed with nanosecond and femtosecond UV lasers. The Solid Films. 18(31): 6504-11.
Dinca V, Ranella A, Farsari M, Kafetzopoulos D, Dinescu M, Popescu A, Fotakis C. 2008. Quantification of the activity of biomolecules in microarrays obtained by direct laser transfer. 10(5): 719-25.
Dinca V, Ranella A, Popescu A, Dinescu M, Farsari M, Fotakis C. 2007. Parameters optimization for biological molecules patterning using 248-nm ultrafast lasers. Applied Surface Science. 254(4): 1164-8.
Espejo A, Cote J, Bednarek A, Richard S, Beford MT. 2002. A protein-domain microarray identifies novel protein–protein interactions. Biochem J. 367: 697-702.
Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF, Liotta LA. 2004. Protein microarray detection strategies: focus on direct detection technologies. Journal of Immunological Methods. 290: 121-33.
Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF, Liotta LA. 2008. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Molecular and Cellular Proteomics. 7(10): 1998-2018.
Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. 2009a. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin. Appl. 3: 874-82.
Espina V, Wulfkuhle J, Liotta LA. 2009b. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clin. Lab. Med. 29(1): 1-13.
Fan Y-H, Hu Z, Li C, Wang L-E, Guo Z, Qiao Y, Zhang L, Zhang W, Mao L, Wei Q. 2007. In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: a multivariate analysis. J. Proteome Res. 6(4): 1560-7.
Feilner T, Chai W. 2004a. Oligosaccharide microarrays to decipher the glyco code. Nature Reviews Molecular Cell Biology. 5: 582-8.
Feilner T, Hultschig C, Lee J, Meyer S, Immink RGH, Koenig A, Possling A, Seitz H, Beveridge A, Scheel D, Cahill DJ, Lehrach H, Kreutzberger J, Kersten K. 2005. High Throughput Identification of Potential Arabidopsis Mitogen-activated Protein Kinases Substrates. Molecular and Cellular Proteomics.
Feilner T, Kersten B. 2007. Phosphorylation studies using plant protein microarrays. Methods Mol. Bio. 355: 379-90.
Feilner T, Kreutzberger J, Niemann B, Kramer A, Possling A, Seitz H, Kersten B. 2004b. Proteomic Studies Using Microarrays. Current Proteomics. 1(4): 283-95.
Feizi T, Fazio F, Chai W, Wong C-H. 2003. Carbohydrate microarrays — a new set of technologies at the frontiers of glycomics. Current Opinion in Structural Biology. 13: 637-45.
Fernández-Madrid F, Tang N, Alansari H, Granda JL, Tait L, Amirikia KC, Moroianu M, Wang X, Karvonen RL. 2004. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer. Cancer Research. 64: 5089-96.
Fröhlich H, Sahin Ö, Arlt D, Bender C, Beißbarth T. 2009. Deterministic Effects Propagation Networks for reconstructing protein signaling networks from multiple interventions. BMC Bioinformatics. 10(322).
Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. 2002. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nature Biotechnology. 20: 1011-17.
Gagné J-P, Isabelle M, Lo KS, Bourassa S, Hendzel MJ, Dawson VL, Dawson TM, Poirier GG. 2008. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Research. 36(22): 6959-76.
Geho D, Lahar N, Gurnani P, Huebschman M, Hermann P, Espina V, Shi A, Wulfkuhle J, Garner H, Petricoin E, Liotta LA, Rosenblatt KP. 2005. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjugate Chem. 16(3): 599-66.
Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JMA. 2008. A single lysis solution for the analysis of tissue samples by different proteomic technologies. Molecular Oncology. 2(4): 368-79.
Grote T, Siwak DR, Fritsche HA, Joy C, Mills GB, Simeone D, Whitcomb DC, Logsdon C. 2008. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer. Proteomics. 8: 3051-60.
Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CD, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF. 2003. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics. 3: 2142-6.
Guilleaume B, Bune A, Schmidt C, Klimek F, Moldenhauer G, Huber W, Arlt D, Korf U, Wiemann S, Poustka A. 2005. Systematic comparison of surface coatings for protein microarrays. Proteomics. 5: 4705-12.
Gul O, Basaga H, Kutuk O. 2008. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures. Briefings in Functional Genomics. 7(1): 27-34.
Gulmann C, Espina V, Petricoin EF, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL. 2005. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin. Cancer Res. 11(16): 5847-55.
Gupta R, Kus R, Fladd C, Wasmuth J, Tonikian R, Sidhu S, Krogan NJ, Parkinson J, Rotin D. 2007. Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast. Molecular Systems Biology. 3:116.
Gutjahr C, Murphy D, Lueking A, Koenig A, Janitz M, O'Brien J, Korn B, Horn S, Lehrach H, Cahill DJ. 2005. Mouse protein arrays from a TH1 cell cDNA library for antibody screening and serum profiling. Genomics. 85(3): 285-96.
Haab BB, Geierstanger BH, Michailidis G, Vitzthum F, Forrester S, Okon R, Saviranta P, Brinker A, Sorette M, Perlee L, Suresh S, Drwal G, Adkins JN, Omenn GS. 2005. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data.Proteomics. 5: 3278-91.
Hall DA, Ptacek J, Snyder M. 2007. Protein Microarray Technology. Mech. Ageing. Dev. 128(1): 161-7.
He M, Wang M-W. 2007. Arraying proteins by cell-free synthesis. Biomolecular Engineering. 24(4): 375-80.
Ho S-W, Ghil J, Chen CTL, Johnston M, Snyder M. 2006. Linking DNA-binding proteins to their recognition sequences by using protein microarrays. PNAS 103(26): 9940-5.
Horn S, Lueking A, Murphy D, Staudt A, Gutjahr C, Schulte K, König A, Landsberger M, Lehrach H, Felix SB, Cahill DJ. 2004. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics. 6(2): 605-13.
Howbrook DN, van der Valk AM, O'Shaughnessy MC, Sarker DK, Baker SC, Lloyd AW. 2003. Developments in microarray technologies. Drug Discovery Today. 8(14): 642-51.
Ivanov SS, Chung AS, Yuang Z-l, Guan Y-i, Sachs KV, Reichner JS, Chin YE. 2004. Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Molecular and Cellular Proteomics. 3(8): 788-95.
Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF. 2002. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics. 2: 76-84.
Jiang L, Yu Z, Du W, Tang Z, Jiang T, Zhang C, Lu Z. 2008. Development of a fluorescent and colorimetric detection methods-based protein microarray for serodiagnosis of TORCH infections. Biosensors and Bioelectronics. 24(3): 376-82.
Kersten B, Feilner T. 2007. Generation of plant protein microarrays and investigation of antigen-antibody interactions. Methods Mol. Biol. 355: 365-78.
Kersten B, Feilner T, Kramer A, Wehrmeyer S, Possling A, Witt I, Zanor MI, Stracke R, Lueking A, Kreutzberger J, Lehrach H, Cahill DJ. 2003. Generation of Arabidopsis protein chips for antibody and serum screening. Plant Molecular Biology. 52: 999-1010.
Kersten B, Possling A, Blaesing F, Mirgorodskaya E, Gobom J, Seitz H. 2004. Protein microarray technology and ultraviolet crosslinking combined with mass spectrometry for the analysis of protein-DNA interactions. Analytical Biochemistry. 331: 303-13.
Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L, Zhang Y, Bedford MT. 2006. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Reports. 7(4): 397-403.
Kim T-E, Park S-W, Cho N-Y, Choi S-Y, Yong T-S, Nahm B-H, Lee S, Noh G. 2002. Quantitative measurement of serum allergen-specific IgE on protein chip. Exp. Mol. Med. 34(2): 152-8.
Kingsmore SF. 2006. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5(4): 310-20.
Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin EF, Krizman DB. 2001. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 1271-78.
Knight PR, Sreekumar A, Siddiqui J, Laxman B, Copeland S, Chinnaiyan A, Remick DG. 2004. Development of a Sensitive Microarray Immunoassay and Comparison with standard Enzyme-Linked Immunoassay for Cytokine Analysis. Shock. 21(1): 26-30.
Kopf E, Shnitzer D, Zharhary D. 2005. Panorama Ab Microarray Cell Signaling kit: A unique tool for protein expression analysis. Proteomics. 5(9): 2412-6.
Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, Coombes KR, Mills GB. 2009. Functional proteomic profiling of AML predicts response and survival. Blood. 113(1): 154-64.
Kramer A, Feilner T, Possling A, Radchuck V, Weschke W, Bürkle L, Kersten B. 2004. Identification of barley CK2a targets by using the protein microarray technology. Phytochemistry 65: 1777-84.
Kreutzberger J. 2006. Protein microarrays: a chance to study microorganisms? Appl. Microbiol. Biotechnol. 70: 383-90.
Kukar T, Eckenrode S, Gu Y, Lian W, Megginson M, She J-X, Wu D. 2002. Protein Microarrays to Detect Protein–Protein Interactions Using Red and Green Fluorescent Proteins. Analytical Biochemistry. 306(1): 50-4.
LaBaer J, Ramachandran N. 2005. Protein microarrays as tools for functional proteomics. Current Opinion in chemical Biology. 9: 14-9.
Lash GE, Scaife PJ, Innes BA, Otun HA, Robson SC, Searle RF, Bulmer JN. 2006.Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight™ and FAST Quant®. J. Immunological Methods. 309(1-2): 205-9.
Li Y, Reichert WM. 2003a. Adapting cDNA microarray format to cytokine detection protein arrays. Langmuir. 19(5): 1557-66.
Li Y, Schutte RJ, Abu-Shakra A, Reichert WM. 2005. Protein array method for assessing in-vitro biomaterial-induced cytokine expression. Biomaterials. 26: 1081-5.
Li Y, Nath N, Reichert WM. 2005. Protein array method for assessing in-vitro biomaterial-induced cytokine expression. Biomaterials. 26: 108-5.
Li Q-Z, Zhou J, Wandstrat AE, Carr-Johnson F, Branch V, Karp DR, Mohan C, Wakeland EK, Olsen NJ. 2006. Protein array autoantibody profiles for insight into systemic lupus erythematosus and incomplete lupus syndrome. Clin. Exp. Immunol. 147: 60-70.
Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. 2009. Pancreatic Cancer Serum Detection Using A Lectin/Glyco-Antibody Array Method. J Proteome Res. 8(2): 483-92.
Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF. 2003. Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell. 3: 317-25.
Liu MY, Cai S, Espejo A, Bedford MT, Walker CL. 2002. 14-3-3 Interacts with the Tumor Suppressor Tuberin at Akt Phosphorylation Site(s). Cancer Research. 62: 6475-80.
Loebke C, Sueltmann H, Schmidt C, Henjes F, Wiemann S, Poustka A, Korf U. 2007. Infrared-based protein detection arrays for quantitative proteomics. Proteomics. 7: 558-64.
Lueking A, Huber O, Wirths C, Schulte K, Stieler KM, Blume-Peytavi U, Kowald A, Hensel-Wiegel K, Tauber R, Lehrach H, Meyer HE, Cahilla DJ. 2005. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics. 4(9): 1382-90.
MacBeath G, Schreiber SL. 2000. Printing Proteins as Microarrays for High-Throughput Function Determination. Science. 289: 1760-3.
MacBeath G. 2002. Protein microarrays and proteomics. Nature Genetics Supplement. 32: 526-32.
Maciewicz RA, Knight PJ. 1988. Transmission densitometry of stained nitrocellulose paper. Analytical Biochemistry. 175(1): 85-90.
Madoz-Gúrpide J, Wang H, Misek DE, Brichory F, Hanash SM. 2001. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues. Proteomics. 1279-87.
McGrath CM, Grudzien JL, Decker DA, Robbins TO. 1991. Cytometrically Coherent Transfer of Receptor Proteins on Microporous Membranes. BioTechniques. 11(3): 352-61.
McGrath CM, Grudzien JL, Levine AJ. 1995a. High Definition Cell Analysis In Situ Using Microporous Films. Cell Vision. 2(6): 499-509.
Michaud GA, Salcius M, Zhou F, Bangham R, Bonin J, Guo H, Snyder M, Predki PF, Schweitzer BI. 2003. Analyzing antibody specificity with whole proteome microarrays. Nature Biotechnology. 21(12): 1509-12.
Mircean C, Shmulevich I, Cogdell D, Choi W, Jia Y, Tabus I, Hamilton SR, Zhang W. 2005. Robust esti
Ajikumar PK, Ng JK, Tang YC, Lee JY, Stephanopoulos G, Too H-P. 2006. Design, fabrication and functional analysis of a new protein array based on ssDNA-based assembly. MEBCS.
Alterovitz G, Liu J, Chow J, Ramoni MF. 2006. Automation, parallelism, and robotics for proteomics. Proteomics.
Angenendt P, GlÖkler J, Sobek J, Lehrach H, Cahill DJ. 2003. Next generation of protein microarray support materials: Evaluation for protein and antibody microarray applications. Journal of Chromatography A. 1009: 97-104.
Arnaud M-C, Gazarian T, Rodriguez YP, Gazarian K, Sakanyan V. 2004. Array assessment of phage-displayed peptide mimics of Human Immunodeficiency Virus type 1 gp41immunodominant epitope: Binding to antibodies of infected individuals. Proteomics. 4: 1959-64.
Averbeck M, Beilharz S, Bauer M, Gebhardt C, Hartmann A, Hochleitner K, Kauer F, Voith U, Simon JC, Termeer C. 2006. In situ profiling and quantification of cytokines released during UVB-induced inflammation by combining dermal microdialysis and protein microarrays. Exp. Dermatol. 15: 447-54.
Aziz SA, Davies M, Pick E, Zito C, Jilaveanu L, Camp RL, Rimm DL, Kluger Y, Kluger HM. 2009. Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma. Clinical Cancer Research. 15(9): 3029-36.
Balboni I, Chan SM, Tenenbaum JD, Butte AJ, Utz PJ. 2006. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 24: 391-418.
Barres BA, Koroshetz WJ, Chun LLY, Corey DP. 1990. Ion Channel Expression by White Matter Glia: The Type-1 Astrocyte. Neuron. 5: 527-44.
Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nährig J, Becker I, Höfler H. 2007. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 211(3): 370-8.
Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RL. 2001. Immunophenotyping of Leukemias Using a Cluster of Differentiation Antibody Microarray. Cancer Research. 61: 4483–9.
Belov L, Huang P, Barber N, Mulligan SP, Christopherson RL. 2003. Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics. 3: 2147-54.
Belov L, Huang P, Chrisp JS, Mulligan SP, Christopherson RI. 2005. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. J Immunological Methods 305: 10-19.
Bouwman K, Qiu J, Zhou H, Schotanus M, Mangold LA, Vogt R, Erlandson E, Trenkle J, Partin AW, Misek D, Omenn GS, Haab BB, Hanash S. 2003. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.
Braun F, Marhuenda FB, Morin A, Guevel L, Fleury F, Takahashi M, Sakanyan V. 2006. Similarity and divergence between the RNA polymerase a subunits from thermophilic Thermotoga maritima and mesophilic Escherichia coli bacteria. Gene 380: 120-6.
Braunschweig T, Kaserer K, Chung J-Y, Bilke S, Krizman D, Knezevic V, Hewitt SM. 2007. Proteomic expression profiling of thyroid neoplasms. Proteomics Clin. 1: 264-71.
Cahill DJ. 2001. Protein and antibody arrays and their medical applications. Journal of Immunological Methods. 250: 81-91.
Calvert VS, Tang Y, Boveia V, Wulfkuhle J, Schutz-Geschwender A, Olive DM, Liotta LA, Petricoin EF. 2004. Development of Multiplexed Protein Profiling and Detection Using Near Infrared Detection of Reverse-Phase Protein Microarrays. Proteomics. 1: 81-9.
Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Liotta LA, Petricoin EF, Younossi ZM. 2007. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology. 46(1): 166-72.
Carbone R, De Marni M, Zanardi A, Vinati S, Barborini E, Fornasari L, Milani P. 2009. Characterization of cluster-assembled nanostructured titanium oxide coatings as substrates for protein arrays. Analytical Biochemistry. 394(1): 7-12.
Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES. 2008. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood. 112(9): 3818-26.
Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. 2004. Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 10(12) 1390-6.
Chang Y-J, Hu C-Y, Yin L-T, Chang C-H, Su H-J. 2008. Dividable membrane with multi-reaction wells for microarray biochips. Journal of Bioscience and Bioengineering. 106(1): 59-64.
Charboneau L, Scott H, Chen T, Winters M, Petricoin EF, Liotta LA, Paweletz CP. 2002. Utility of reverse phase protein arrays: Applications to signalling pathways and human body arrays. Briefings in functional Genomics and Proteomics. 1(3): 305-15.
Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. 2006. Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays. Cancer Research. 66: 1181-90.
Chatterjee M, Ionan A, Draghici S, Tainsky MA. 2006. Epitomics: global profiling of immune response to disease using protein microarrays. OMICS. 10(4): 499-506.
Cho WCS. 2007. Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer. 6(25).
Christopherson RI, Stoner K, Barber N, Belov L, Woolfson A, Scott M, Bendall L, Mulligan SP. 2006. Classification of AML using a monoclonal antibody microarray. Methods Mol. Med. 125: 241-51.
Cinier M, Petit M, Williams MN, Fabre RM, Pecorari F, Talham DR, Bujoli B, Tellier C. 2009. Bisphosphonate Adaptors for Specific Protein Binding on Zirconium Phosphonate-based Microarrays. Bioconjugate Chem. 20(12): 2270-7.
Colombo JA, Napp MI, Yáñez A, Reisin H. 2001. Tissue printing of astroglial interlaminar processes from human and non-human primate cerebral cortex. Brain Research Bulletin. 55(4): 561-5.
Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, Romero KM, Nguyen TT, Kalantari-Dehaghi M, Crotty S, Baldi P, Villarreal LP, Felgner PL. 2005a. Profiling the humoral response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery. PNAS. 102(3): 547-52.
Davies DH, McCausland MM, Valdez C, Huynh D, Hernandez JE, Mu Y, Hirst S, Villarreal L, Felgner PL, Crotty S. 2005b. Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice. Journal of Virology. 79(18): 11724-33.
Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, Mu Y, Pablo J, Unal B, Nakajima-Sasaki R, Liang X, Crotty S, Karem KL, Damon IK, Ahmed R, Villarreal L, Felgner P. 2007. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics. 7: 1678-86.
Davuluri G, Espina V, Petricoin EF, Ross M, Deng J, Liotta LA, Glaser BM. 2009. Activated VEGF receptor shed into the vitreous in eyes with wet AMD. Archives of Ophthalmology. 127(5): 613-21.
Dinca V, Catherine J, Mourka A, Georgiou S, Farsari M, Fotakis C. 2009. 2D and 3D biotin patterning by ultrafast lasers. International ournal of Nanotechnology. 6(1-2): 88-98.
Dinca V, Farsari M, Kafetzopoulos D, Popescu A, Dinescu M, Fotakis C. 2008. Patterning parameters for biomolecules microarrays constructed with nanosecond and femtosecond UV lasers. The Solid Films. 18(31): 6504-11.
Dinca V, Ranella A, Farsari M, Kafetzopoulos D, Dinescu M, Popescu A, Fotakis C. 2008. Quantification of the activity of biomolecules in microarrays obtained by direct laser transfer. 10(5): 719-25.
Dinca V, Ranella A, Popescu A, Dinescu M, Farsari M, Fotakis C. 2007. Parameters optimization for biological molecules patterning using 248-nm ultrafast lasers. Applied Surface Science. 254(4): 1164-8.
Espejo A, Cote J, Bednarek A, Richard S, Beford MT. 2002. A protein-domain microarray identifies novel protein–protein interactions. Biochem J. 367: 697-702.
Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF, Liotta LA. 2004. Protein microarray detection strategies: focus on direct detection technologies. Journal of Immunological Methods. 290: 121-33.
Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF, Liotta LA. 2008. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Molecular and Cellular Proteomics. 7(10): 1998-2018.
Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. 2009a. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin. Appl. 3: 874-82.
Espina V, Wulfkuhle J, Liotta LA. 2009b. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clin. Lab. Med. 29(1): 1-13.
Fan Y-H, Hu Z, Li C, Wang L-E, Guo Z, Qiao Y, Zhang L, Zhang W, Mao L, Wei Q. 2007. In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: a multivariate analysis. J. Proteome Res. 6(4): 1560-7.
Feilner T, Chai W. 2004a. Oligosaccharide microarrays to decipher the glyco code. Nature Reviews Molecular Cell Biology. 5: 582-8.
Feilner T, Hultschig C, Lee J, Meyer S, Immink RGH, Koenig A, Possling A, Seitz H, Beveridge A, Scheel D, Cahill DJ, Lehrach H, Kreutzberger J, Kersten K. 2005. High Throughput Identification of Potential Arabidopsis Mitogen-activated Protein Kinases Substrates. Molecular and Cellular Proteomics.
Feilner T, Kersten B. 2007. Phosphorylation studies using plant protein microarrays. Methods Mol. Bio. 355: 379-90.
Feilner T, Kreutzberger J, Niemann B, Kramer A, Possling A, Seitz H, Kersten B. 2004b. Proteomic Studies Using Microarrays. Current Proteomics. 1(4): 283-95.
Feizi T, Fazio F, Chai W, Wong C-H. 2003. Carbohydrate microarrays — a new set of technologies at the frontiers of glycomics. Current Opinion in Structural Biology. 13: 637-45.
Fernández-Madrid F, Tang N, Alansari H, Granda JL, Tait L, Amirikia KC, Moroianu M, Wang X, Karvonen RL. 2004. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer. Cancer Research. 64: 5089-96.
Fröhlich H, Sahin Ö, Arlt D, Bender C, Beißbarth T. 2009. Deterministic Effects Propagation Networks for reconstructing protein signaling networks from multiple interventions. BMC Bioinformatics. 10(322).
Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. 2002. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nature Biotechnology. 20: 1011-17.
Gagné J-P, Isabelle M, Lo KS, Bourassa S, Hendzel MJ, Dawson VL, Dawson TM, Poirier GG. 2008. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Research. 36(22): 6959-76.
Geho D, Lahar N, Gurnani P, Huebschman M, Hermann P, Espina V, Shi A, Wulfkuhle J, Garner H, Petricoin E, Liotta LA, Rosenblatt KP. 2005. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjugate Chem. 16(3): 599-66.
Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JMA. 2008. A single lysis solution for the analysis of tissue samples by different proteomic technologies. Molecular Oncology. 2(4): 368-79.
Grote T, Siwak DR, Fritsche HA, Joy C, Mills GB, Simeone D, Whitcomb DC, Logsdon C. 2008. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer. Proteomics. 8: 3051-60.
Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CD, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF. 2003. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics. 3: 2142-6.
Guilleaume B, Bune A, Schmidt C, Klimek F, Moldenhauer G, Huber W, Arlt D, Korf U, Wiemann S, Poustka A. 2005. Systematic comparison of surface coatings for protein microarrays. Proteomics. 5: 4705-12.
Gul O, Basaga H, Kutuk O. 2008. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures. Briefings in Functional Genomics. 7(1): 27-34.
Gulmann C, Espina V, Petricoin EF, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL. 2005. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin. Cancer Res. 11(16): 5847-55.
Gupta R, Kus R, Fladd C, Wasmuth J, Tonikian R, Sidhu S, Krogan NJ, Parkinson J, Rotin D. 2007. Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast. Molecular Systems Biology. 3:116.
Gutjahr C, Murphy D, Lueking A, Koenig A, Janitz M, O'Brien J, Korn B, Horn S, Lehrach H, Cahill DJ. 2005. Mouse protein arrays from a TH1 cell cDNA library for antibody screening and serum profiling. Genomics. 85(3): 285-96.
Haab BB, Geierstanger BH, Michailidis G, Vitzthum F, Forrester S, Okon R, Saviranta P, Brinker A, Sorette M, Perlee L, Suresh S, Drwal G, Adkins JN, Omenn GS. 2005. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data.Proteomics. 5: 3278-91.
Hall DA, Ptacek J, Snyder M. 2007. Protein Microarray Technology. Mech. Ageing. Dev. 128(1): 161-7.
He M, Wang M-W. 2007. Arraying proteins by cell-free synthesis. Biomolecular Engineering. 24(4): 375-80.
Ho S-W, Ghil J, Chen CTL, Johnston M, Snyder M. 2006. Linking DNA-binding proteins to their recognition sequences by using protein microarrays. PNAS 103(26): 9940-5.
Horn S, Lueking A, Murphy D, Staudt A, Gutjahr C, Schulte K, König A, Landsberger M, Lehrach H, Felix SB, Cahill DJ. 2004. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics. 6(2): 605-13.
Howbrook DN, van der Valk AM, O'Shaughnessy MC, Sarker DK, Baker SC, Lloyd AW. 2003. Developments in microarray technologies. Drug Discovery Today. 8(14): 642-51.
Ivanov SS, Chung AS, Yuang Z-l, Guan Y-i, Sachs KV, Reichner JS, Chin YE. 2004. Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Molecular and Cellular Proteomics. 3(8): 788-95.
Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF. 2002. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics. 2: 76-84.
Jiang L, Yu Z, Du W, Tang Z, Jiang T, Zhang C, Lu Z. 2008. Development of a fluorescent and colorimetric detection methods-based protein microarray for serodiagnosis of TORCH infections. Biosensors and Bioelectronics. 24(3): 376-82.
Kersten B, Feilner T. 2007. Generation of plant protein microarrays and investigation of antigen-antibody interactions. Methods Mol. Biol. 355: 365-78.
Kersten B, Feilner T, Kramer A, Wehrmeyer S, Possling A, Witt I, Zanor MI, Stracke R, Lueking A, Kreutzberger J, Lehrach H, Cahill DJ. 2003. Generation of Arabidopsis protein chips for antibody and serum screening. Plant Molecular Biology. 52: 999-1010.
Kersten B, Possling A, Blaesing F, Mirgorodskaya E, Gobom J, Seitz H. 2004. Protein microarray technology and ultraviolet crosslinking combined with mass spectrometry for the analysis of protein-DNA interactions. Analytical Biochemistry. 331: 303-13.
Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L, Zhang Y, Bedford MT. 2006. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Reports. 7(4): 397-403.
Kim T-E, Park S-W, Cho N-Y, Choi S-Y, Yong T-S, Nahm B-H, Lee S, Noh G. 2002. Quantitative measurement of serum allergen-specific IgE on protein chip. Exp. Mol. Med. 34(2): 152-8.
Kingsmore SF. 2006. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5(4): 310-20.
Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin EF, Krizman DB. 2001. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 1271-78.
Knight PR, Sreekumar A, Siddiqui J, Laxman B, Copeland S, Chinnaiyan A, Remick DG. 2004. Development of a Sensitive Microarray Immunoassay and Comparison with standard Enzyme-Linked Immunoassay for Cytokine Analysis. Shock. 21(1): 26-30.
Kopf E, Shnitzer D, Zharhary D. 2005. Panorama Ab Microarray Cell Signaling kit: A unique tool for protein expression analysis. Proteomics. 5(9): 2412-6.
Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, Coombes KR, Mills GB. 2009. Functional proteomic profiling of AML predicts response and survival. Blood. 113(1): 154-64.
Kramer A, Feilner T, Possling A, Radchuck V, Weschke W, Bürkle L, Kersten B. 2004. Identification of barley CK2a targets by using the protein microarray technology. Phytochemistry 65: 1777-84.
Kreutzberger J. 2006. Protein microarrays: a chance to study microorganisms? Appl. Microbiol. Biotechnol. 70: 383-90.
Kukar T, Eckenrode S, Gu Y, Lian W, Megginson M, She J-X, Wu D. 2002. Protein Microarrays to Detect Protein–Protein Interactions Using Red and Green Fluorescent Proteins. Analytical Biochemistry. 306(1): 50-4.
LaBaer J, Ramachandran N. 2005. Protein microarrays as tools for functional proteomics. Current Opinion in chemical Biology. 9: 14-9.
Lash GE, Scaife PJ, Innes BA, Otun HA, Robson SC, Searle RF, Bulmer JN. 2006.Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight™ and FAST Quant®. J. Immunological Methods. 309(1-2): 205-9.
Li Y, Reichert WM. 2003a. Adapting cDNA microarray format to cytokine detection protein arrays. Langmuir. 19(5): 1557-66.
Li Y, Schutte RJ, Abu-Shakra A, Reichert WM. 2005. Protein array method for assessing in-vitro biomaterial-induced cytokine expression. Biomaterials. 26: 1081-5.
Li Y, Nath N, Reichert WM. 2005. Protein array method for assessing in-vitro biomaterial-induced cytokine expression. Biomaterials. 26: 108-5.
Li Q-Z, Zhou J, Wandstrat AE, Carr-Johnson F, Branch V, Karp DR, Mohan C, Wakeland EK, Olsen NJ. 2006. Protein array autoantibody profiles for insight into systemic lupus erythematosus and incomplete lupus syndrome. Clin. Exp. Immunol. 147: 60-70.
Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. 2009. Pancreatic Cancer Serum Detection Using A Lectin/Glyco-Antibody Array Method. J Proteome Res. 8(2): 483-92.
Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF. 2003. Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell. 3: 317-25.
Liu MY, Cai S, Espejo A, Bedford MT, Walker CL. 2002. 14-3-3 Interacts with the Tumor Suppressor Tuberin at Akt Phosphorylation Site(s). Cancer Research. 62: 6475-80.
Loebke C, Sueltmann H, Schmidt C, Henjes F, Wiemann S, Poustka A, Korf U. 2007. Infrared-based protein detection arrays for quantitative proteomics. Proteomics. 7: 558-64.
Lueking A, Huber O, Wirths C, Schulte K, Stieler KM, Blume-Peytavi U, Kowald A, Hensel-Wiegel K, Tauber R, Lehrach H, Meyer HE, Cahilla DJ. 2005. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics. 4(9): 1382-90.
MacBeath G, Schreiber SL. 2000. Printing Proteins as Microarrays for High-Throughput Function Determination. Science. 289: 1760-3.
MacBeath G. 2002. Protein microarrays and proteomics. Nature Genetics Supplement. 32: 526-32.
Maciewicz RA, Knight PJ. 1988. Transmission densitometry of stained nitrocellulose paper. Analytical Biochemistry. 175(1): 85-90.
Madoz-Gúrpide J, Wang H, Misek DE, Brichory F, Hanash SM. 2001. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues. Proteomics. 1279-87.
McGrath CM, Grudzien JL, Decker DA, Robbins TO. 1991. Cytometrically Coherent Transfer of Receptor Proteins on Microporous Membranes. BioTechniques. 11(3): 352-61.
McGrath CM, Grudzien JL, Levine AJ. 1995a. High Definition Cell Analysis In Situ Using Microporous Films. Cell Vision. 2(6): 499-509.
Michaud GA, Salcius M, Zhou F, Bangham R, Bonin J, Guo H, Snyder M, Predki PF, Schweitzer BI. 2003. Analyzing antibody specificity with whole proteome microarrays. Nature Biotechnology. 21(12): 1509-12.
Mircean C, Shmulevich I, Cogdell D, Choi W, Jia Y, Tabus I, Hamilton SR, Zhang W. 2005. Robust esti